Open Access

The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisation

  • Christine Felix1, 2,
  • Burcu Kaplan Türköz3, 4,
  • Sebastien Ranaldi1, 2,
  • Thomas Koelblen3,
  • Laurent Terradot3,
  • David O’Callaghan1, 2 and
  • Annette Caroline Vergunst1, 2Email author
Cell Communication and Signaling201412:53

Received: 19 March 2014

Accepted: 27 August 2014

Published: 12 October 2014



The TIR domain-containing proteins BtpA/Btp1/TcpB and BtpB are translocated into host cells by the facultative intracellular bacterial pathogen Brucella. Here, they interfere with Toll like receptor signalling to temper the host inflammatory response. BtpA has also been found to modulate microtubule dynamics. In both proteins we identified a WxxxE motif, previously shown to be an essential structural component in a family of bacterial type III secretion system effectors that modulate host actin dynamics by functioning as guanine nucleotide exchange factors of host GTPases. We analysed a role for the WxxxE motif in association of BtpA and BtpB with the cytoskeleton.


Unlike BtpA, ectopically expressed BtpB did not show a tubular localisation, but was found ubiquitously in the cytoplasm and the nucleus, and often appeared in discrete punctae in HeLa cells. BtpB was able to protect microtubules from drug-induced destabilisation similar to BtpA. The WxxxE motif was important for the ability of BtpA and BtpB to protect microtubules against destabilising drugs. Surprisingly, ectopic expression of BtpA, although not BtpB, in HeLa cells induced the formation of filopodia. This process was invariably dependent of the WxxxE motif. Our recent resolution of the crystal structure of the BtpA TIR domain reveals that the motif positions a glycine residue that has previously been shown to be essential for interaction of BtpA with microtubules.


Our results suggest a structural role for the WxxxE motif in the association of BtpA and BtpB with microtubules, as with the WxxxE GEF family proteins where the motif positions an adjacent catalytic loop important for interaction with specific Rho GTPases. In addition, the ability of ectopically expressed BtpA to induce filopodia in a WxxxE-dependent manner suggests a novel property for BtpA. A conserved WxxxE motif is found in most bacterial and several eukaryotic TIR domain proteins. Despite the similarity between ectopically expressed BtpA and WxxxE GEFs to modulate host actin dynamics, our results suggest that BtpA is not part of this WxxxE GEF family. The WxxxE motif may therefore be a more common structural motif than thus far described. BtpA may provide clues to cross-talk between the TLR and GTPase signalling pathways.


BtpA TcpB BtpB Brucella Bacterial TIR domain proteins TIR domain WxxxE motif GTPase signalling Microtubule dynamics


Brucella is a Gram negative facultative intracellular bacterium that can cause brucellosis or Malta Fever, the world's most widespread zoonotic disease [1]. In humans Brucella causes an undulant fever that can be accompanied by complications such as endocarditis, arthritis and osteomyelitis [2]. Brucella is a stealth pathogen, known for its silent entry into host cells and multiple mechanisms to suppress host innate immune signalling, including non-toxic lipid A, and avoidance of oxidative burst and Toll like receptor (TLR) signalling cascades [2]-[6]. Whereas the primary task of immune cells is to phagocytose and degrade microbes, many intracellular pathogens, including Brucella, use secretion systems to introduce bacterial effector proteins directly into host cells to alter host cell biology and favour their intracellular replication [7],[8]. For full virulence, Brucella requires its VirB type IV secretion system (T4SS) to modulate endosomal trafficking, and create a replication niche in ER-derived membrane vesicles, named Brucella containing vacuoles (BCV) [9]-[11]. For many years, the effector proteins translocated by the Brucella VirB system remained elusive. After the identification of a first candidate [12], recent efforts from several laboratories, using both bioinformatics screens and translocation assays have resulted in a list of possible effectors [13]-[16]. To date, the precise role of most of these proteins in Brucella virulence is still not clear and the subject of intense research.

Recently, the proteins BtpA (Btp1/TcpB) and BtpB have been shown to be translocated by Brucella into host cells [17]. Although a TEM-1 β-lactamase assay did not show a significant difference in translocation efficiency of the proteins from wild type and virB mutant bacteria, a CyA reporter assay showed VirB-dependent protein transport into host cells, suggesting BtpA and BtpB may be substrates of the VirB T4SS. BtpA and BtpB belong to a class of bacterial proteins first described in Salmonella, Escherichia coli and Brucella that share homology with the eukaryotic Toll/Interleukin-1 receptor (TIR) domain [18],[19]. A conserved TIR domain is present in eukaryotic TLR proteins as well as their downstream signalling TIR adaptor proteins, including the central cytosolic adapter protein MyD88. The TIR domain is essential for TLR and adaptor interactions and for the onset of a signalling cascade resulting in nuclear translocation of the transcription factor NFκB, followed by the production of pro-inflammatory cytokines and type I interferons [20]. TIR domain interactions play a key role in activating conserved cellular signal transduction pathways in response to pathogen signals, and it was suggested that bacterial TIR proteins interfere with host TLR defence signalling by molecular mimicry (reviewed in [21]).

B. abortus 2308 BtpA (BAB1_0279) and the almost identical B. melitensis 16M BtpA (BMEI1674) down modulate maturation of dendritic cells [22] and inhibit TLR-induced NFκB activation. It has been suggested that this is through interference with the TLR4/MyD88/TIRAP complex [23]-[27], however the exact binding partner of BtpA is still a subject of controversy. Far less is known about BtpB, however recently it has also been shown to play a role in immune modulation [17]. Recently we, and others, published the crystal structure of the BtpA TIR domain, which showed a dimeric arrangement of a canonical TIR domain [25],[28],[29], but significant differences in loop structures suggest that these proteins could interfere with intrinsic host TLR signalling pathways. These recent advances will help to more precisely determine the exact molecular mechanisms of this molecular mimicry, and to further address the different roles these proteins may play in virulence.

In addition to an important role for BtpA and BtpB in inhibiting TLR-mediated immune responses, in vitro and overexpression studies have shown that BtpA tightly interacts with microtubules and is able to stabilize polymerized microtubules by inhibiting microtubule disassembly induced by the microtubule-drug nocodazole [30]. Here we show that BtpB, in addition to BtpA, is also able to protect microtubules from drug-induced depolymerization. We have identified a WxxxE motif in BtpA and BtpB. A conserved WxxxE motif has been shown to have a structural role in a family of T3SS effectors, which transiently subvert host actin dynamics by functioning as Guanine nucleotide Exchange Factors (GEFs) of Rho GTPases [31],[32]. We provide evidence that the WxxxE motif in BtpA and BtpB is an important structural determinant for protection of microtubules suggesting a functional association with microtubules for both proteins. In addition, we show that ectopically expressed BtpA induces the formation of filopodia in a WxxxE-dependent manner. Our results are supported by the crystal structure of BtpA.


A conserved WxxxE motif in BtpA organizes functional surface loops

BtpA and BtpB have both been shown to have immune modulatory functions in the host cell through their TIR domains by directly interfering with TLR signalling [17], supported by recent structural information [25],[28],[29]. btpA and btpB are located on different genomic islands [33]. We analysed 407 genomes in the PATRIC database (, January 2014). Whereas the GI carrying btpB is found in the genomes of all the classical Brucella strains, the GI containing btpA shows variable distribution (Additional file 1: Figure S1). The btpA and btpB genes show 11% amino acid identity, and are highly conserved throughout the genus. In addition to the well-studied TIR domain, we found that BtpA and BtpB contain a WxxxE motif (Figure 1) (except in all B. melitensis which have the Trp residue changed into Arg in BtpB). A conserved WxxxE structural motif has been described to be important in a family of bacterial type III secretion system effectors, including Shigella IpgB1 and enteropathogenic Escherichia coli Map (Figure 2A), for their function as guanine nucleotide exchange (GEF) mimics for Rho GTPases [31],[34].
Figure 1

Btp protein structure, and sequence alignment indicating TIR domains and position of WxxxE motif. (A) Schematic representation of the Brucella BtpA and BtpB proteins with the position of TIR domain boxes and WxxxE motif indicated. (B) Multiple sequence alignment of Brucella melitensis BtpA (AAL52855.1), Brucella suis BtpB (AAN29664.1), Paracoccus denitrificans PdTir (3H16_D), Salmonella enterica TlpA (WP_000116933.1), Escherichia coli TcpC (ADO30450), Yersinia pestis YpTdp (NP_669733.1), human TLR1 (AAY85643.1), human TLR2 (AGR82491.1), human TLR4 (AAY82267.1), human TLR10 (AAY78485.1), SARM (AAH40429.1), Mal/TIRAP (AF406652_1), TRIF (AAH09860), TRAM (NP_067681), MyD88 (AAB49967.1). The alignment shows the sequence encompassing the TIR domain boxes 1 and 2, and WxxxE motif. The alignment was performed with T-coffee analysis, and edited using Jalview, using the ClustalX colour scheme. Structural features indicated above the sequence alignment according to Kaplan-Türköz [28]. The residues mutated in this study are indicated with red (W213, E217, and G183) and black (I226) dots.

Figure 2

Conservation of the WxxxE motif. (A). Sequence alignment of the WxxxE containing T3SS effectors Map, IpgB1 and SifA; the bacterial TIR proteins BtpA, BtpB, PdTir, TcpC and TlpA; and eukaryotic hTLR2, hTIRAP and hMyD88. (B). Structural comparison of Map (yellow) and BtpA (slate) structure depicted as ribbons and highlighting the residues W and E (purple), and catalytic and BB loops (blue). Side chains are shown in ball and sticks for the residues involved in the structural scaffold (see text for details). (C). Comparison of the WxxxE motif (with W and E residues shown as red balls and sticks) and BB loop (blue) organisation in the structures of PdTir (gold), TLR2 (green) and TIRAP (wheat).

A large family of TIR proteins in both pathogenic and non-pathogenic bacteria has recently been described [21],[35]. Interestingly, sequence alignment shows that the WxxxE motif is highly conserved among the bacterial TIR proteins, including Paracoccus denitrificans PdTir, Yersinia pestis YpTdp, Salmonella enterica TlpA, and Escherichia coli TcpC (Figures 1B, 2A) and eukaryotic TLR proteins (TLR1, 2, 4, 6 and 10). Although the motif is not conserved in the TIR adaptor proteins TIRAP/Mal, TRAM, MyD88 and TRIF, it is present in SARM (Figure 1B), the only TIR adaptor protein that has been shown to negatively regulate TLR signalling [36]. The conservation of the WxxxE motif in a large number of TIR domain proteins suggests the WxxxE motif could have an important structural role, as shown for the WxxxE GEF family proteins.

In the bacterial GEF proteins, the WxxxE motif has been shown to be instrumental in positioning the so-called catalytic loop that participates in the interaction with GTPases such as Cdc42 or Rac [37] (Figure 2A). In the BtpA structure, the WxxxE motif is located in the αC helix (Figure 1B) and interacts with the C-terminal part of the BB loop (Figure 2B). The nitrogen of the tryptophan ring interacts with the hydroxyl group of the D184 main chain while the side chain of E217 interacts with the S185 (Figure 2B). This organization is reminiscent of the WxxxE bonding with the SS motif of the catalytic loop in the EPEC Map effector ([34], Figure 2B). In BtpA, however, this interaction positions a glycine residue (G183) in close proximity to the WxxxE pocket (Figure 2B). Interestingly, G183 has been shown to be important for interaction of BtpA with microtubules (G158 in [23],[24]). Other than the WxxxE motif, no significant structural sequence similarity is present between known WxxxE family GEFs and BtpA. It is of note that the Brucella BtpB protein does not have the G residue at the corresponding position.

Despite the high degree of conservation of the WxxxE motif in the family of bacterial and eukaryotic TIR proteins, structural comparison between the available structures indicates that the interaction between the WxxxE motif and the D residue in the BB loop only occurs in BtpA and PdTIR, and not any of the eukaryotic TIR proteins (Figure 2C). In TLR2 for instance, the WxxxE packs against the DD loop and αD helix (Figure 2C). Together, these observations indicate that a conserved WxxxE motif may be an important structural component in a family of bacterial TIR proteins by positioning different loop structures. More specifically, in BtpA the WxxxE motif may play a structural role by positioning the G183 residue for interaction with microtubules.

The WxxxE motif is important for subcellular localisation of BtpA and protection of microtubules

Besides its important role in interference with TLR signalling BtpA has been shown to modulate microtubule dynamics and protect microtubules from drug-induced depolymerisation [30]. To address a possible role for the WxxxE motif in interaction of BtpA with microtubules, we performed ectopic expression analysis to study the subcellular localisation of the wild type protein and a panel of variants. We created N-terminal fusions of BtpA to GFP in a eukaryotic expression plasmid, and transfected HeLa cells. Confocal and fluorescence microscopy showed that GFP-BtpA formed a filamentous network in the cell (Additional file 2: Figure S2, and Figure 3C, and [24]). In contrast to Radhakrishnan et al. [24], we did not find any evidence for rounding up or shrinkage of cells. Importantly, localisation of BtpA was similar when expressed without the GFP tag and detected with anti-BtpA antibodies (data not shown).
Figure 3

Interaction with and stabilization of microtubules by BtpA against Nocodazole-induced depolymerization is WxxxE-dependent. HeLa cells were transfected with plasmids expressing GFP-BtpA (C, D), GFP-BtpA WxxxE variants (E-L), or I226S (M), respectively. Sixteen hours after transfection cells were either left untreated (A, C, E, G, I, K) or treated with 1 μg/ml nocodazole for 30 min (B, D, F, H, J, L, M). Nocodazole-treated and control cells were fixed and stained with mouse anti β-tubulin antibody, followed by detection with anti-mouse Texas Red, and analysed by fluorescence microscopy. (A) Fluorescent image of tubulin-stained non-transfected control cells (B) Fluorescent image of non-transfected, nocodazole-treated cells. (C-M) Individual green and red fluorescent images and overlay image of HeLa cells expressing (C-D) GFP-BtpA, (E-F) GFP-BtpA W213A, (G-H) GFP-BtpA W213S, (I-J) GFP-BtpA W213F, (K-L) GFP-BtpA E217A, (M) GFP-BtpA I226S. Arrow heads indicate individual cells showing inhibition of nocodazole-induced microtubule depolymerization by expression of (D) GFP-BtpA, (F) GFP-BtpA W213A, and (M) and I226S, in contrast to non-transfected cells. Arrows indicate nocodazole-induced microtubule depolymerization in individual cells expressing (H) GFP-BtpA W213S, (J) GFP-BtpA W213F, (L) GFP-BtpA E217A. Scale bar, 25 μm indicated in A applies to all individual green and red fluorescent images. The overlay images are close ups of individual cells in the corresponding red and green fluorescent images. Data are representative of 3 or more independent experiments.

GFP-BtpA predominantly colocalised with microtubules, labelled with anti-β-tubulin antibodies (Additional file 3: Figure S3, and [24]). Confocal imaging clearly showed that the BtpA tubules localised at the periphery of the cell and, although not colocalising along the complete microtubule network, they showed a regular interaction with the cytoskeleton. Similar to observations reported by Radhakrishnan and colleagues, BtpA could prevent the microtubule destabilizing effect of nocodazole (Figure 3C, D).

Next, we analysed the subcellular localisation of different GFP-BtpA WxxxE variants and their effect on microtubule destabilisation by nocodazole. Using site-directed mutagenesis with the GFP-BtpA expression plasmid as a template, the substitutions W213A, W213F, W213S, E217D, E217A, as well as I226S, and G183A were introduced. Despite very low amino acid sequence homology between BtpA and BtpB, and members of the WxxxE GEF family, we identified a conserved isoleucine residue, 9 amino acids downstream of the WxxxE motif and included a variant in our study. Subcellular localisation of the GFP-fusion proteins was confirmed using BtpA antibodies (data not shown). The different GFP-BtpA variants were ectopically expressed in HeLa cells and details are presented in Table 1 and Figure 3. Although the W213A variant behaved as wild type BtpA, both in subcellular localisation as well as its ability to prevent microtubule destabilisation (Figure 3E, F), substitution of W213 with F or S resulted in a diffuse GFP signal in the cell, indicating these changes greatly affected the localisation of GFP-BtpA. Not localising with microtubules was correlated with the inability of these variant proteins to protect microtubules from degradation by nocodazole (Figure 3G-J); interestingly, in 1.9% of the transfected cells the W213F variant localised in a tubular structure and, in these cells, was able to prevent degradation of microtubules, showing the substitution did not affect the ability of the W213F variant to protect microtubules from depolymerisation when localised correctly.
Table 1

Influence of mutations in the WxxxE motif of BtpA and BtpB on subcellular localisation, microtubule-protection and filopodia induction

BtpA or variant

Localisation of GFP-BtpA in filaments (% of transfected cells ± SD)

Protection of microtubules after NC treatment(% of cells with BtpA arranged in filaments)a

Induction of filopodia(% of cells with BtpA arranged in filaments)b


90.5 ± 1.36

73,8 ± 3.45

75.9 ± 0.26

BtpA W213S




BtpA W213A

90.1 ± 3.86

75,6 ± 5,00


BtpA W213F

81.9 ± 1.81

87,1 ± 5,36


BtpA E217D

1.3 ± 0.78

83.9 ± 9.89


BtpA E217A

52.6 ± 6.67



BtpA I226S

14.4 ± 1.93

76,1 ± 3,66

69.7 ± 3.5

BtpA G183A




BtpB or variant

Protection of microtubules after NC treatment (% of cells with) c

Induction of filopodia


Diffuse BtpB pattern

Punctate BtpB pattern



24.5 ± 0.71

82,2 ± 1.59


BtpB W263S




BtpB E267A




HeLa cells were transfected with plasmid DNA harbouring pCMV:GFP-BtpA, pCMV:GFP-BtpB or the respective Btp variants. After 16–20 hours cells were left untreated or treated with 1 μg/ml nocodazole for 30 min and fixed. Microtubules were visualised using β-tubulin antibodies and detected with Texas-Red conjugated secondary antibodies. For localisation studies, at least 200 transfected cells were analysed per variant per experiment. Data are given in average percentage of transfected cells ± SD (of three independent experiments per variant). For analysis of filopodia, cells were fixed 16-20h hours after transfection, and actin detected with Rhodamine Phalloidin. Each variant was analysed in at least 3 independent experiments.

aFor wildtype BtpA and variants, protection of nocodazole-induced microtubule destabilisation was observed only in transfected cells showing BtpA in filaments. Indicated is the average percentage of cells with filaments that show protection, calculated from two individual experiments (±SD). Cells that showed partial protection were not taken into consideration. At least 100 cells per experiment were counted for BtpA wildtype, BtpA W213A, and BtpAI226S. For BtpA W213F and BtpA E217D, seen the low percentage of transfected cells with BtpA localising in filaments, about 12 cells with BtpA organised in filaments were counted in 2 independent experiments. BtpA W213S, BtpAE217A and BtpAG183A did not show any protection.

bWildtype BtpA and the I226S variant showed induction of filopodia only in transfected cells showing BtpA in filaments. Counts are based on a total of 67 cells with BtpA in filaments in each of 2 independent experiments.

cBtpB transfected cells showed a large variation in ectopic expression phenotypes: Low GFP expression, high GFP expression, and with or without punctae (varying from 1 to over 50). As for BtpA, cells showing partial protection were not taken into account. In two independent experiments 62 and 48 cells (of which 32.7% ± 10.8 were cells without punctae), respectively were analysed for protection of microtubules.

The E217A variant, however, was still found in tubular structures in approximately 53% of the transfected cells yet, in contrast to the W213A and W213F variants, was unable to prevent degradation of microtubules by nocodazole even in those cells (Figure 3K, L). Interestingly, a conservative substitution resulting in the E217D variant, greatly affected GFP-BtpA localisation (Table 1), but again, in about 1% of the transfected cells the E217D variant localised in a tubular structure and in these cells was able to prevent degradation of microtubules. These results demonstrate that the Glu residue is also important for localisation of GFP-BtpA, and suggest in addition that negative charge at this position is essential for the ability of BtpA to protect microtubules from degradation.

The G183 residue lays adjacent to the WxxxE motif in the BtpA crystal structure (Figure 2B). The G183A variant behaved as reported earlier [24] and was unable to colocalise with microtubules, and expectedly unable to prevent microtubule degradation (not shown). The I226S variant formed a tubular network in about 14% of the cells (Table 1), and was able to prevent microtubule degradation in these cells (Figure 3M), showing that this residue is not critical for the ability of BtpA to protect microtubules. Together, our results show that the WxxxE motif is important for both subcellular localisation of BtpA and its ability to protect microtubules from nocodazole-induced depolymerisation.

BtpB protects microtubules from degradation in a WxxxE-dependent manner

Although a role for BtpB in modulation of TLR signalling has been reported recently [17], it is not known whether BtpB associates with microtubules in a manner similar to BtpA. First, we performed ectopic expression analysis to study the subcellular localisation of BtpB. We created an N-terminal fusion of BtpB to GFP in a eukaryotic expression plasmid, and transfected HeLa cells. Using confocal and fluorescence microscopy we observed that, unlike BtpA, GFP-BtpB did not localise in filaments, but was found ubiquitously in the cytoplasm and the nucleus (Figures 4A-D, 5A), with an expression pattern varying from a diffuse GFP signal in about 50% of cells to cells which additionally showed accumulation of GFP-BtpB in one or more discrete punctae (Additional file 4: Figure S4). These discrete structures were heterogeneous in size and detected in the cytoplasm as well as the nucleus (Figure 4B). Surprisingly, in microtubule protection assays we found that BtpB was, like BtpA, able to prevent microtubules from depolymerisation by nocodazole (Figures 4E, F; 5B), suggesting that BtpB might be a microtubule-associated protein with a strong microtubule stabilizing property. Analysis of the number of transfected cells showing either complete or no protection indicated that 63.4% (±7.55, n = 110, 2 independent experiments, Table 1) showed protection of the microtubule network from depolymerisation. Full protection from nocodazole-induced destabilisation was found in a higher percentage of cells showing (at least one) BtpB puncta (82.2%), compared to protection found in cells with a diffuse BtpB signal only (24.5%) (see Table 1). This suggests that, although not crucial, the accumulation of BtpB at these visible discrete sites correlated with better protection of microtubules after nocodazole treatment.
Figure 4

BtpB subcellular localisation. HeLa cells were transiently transfected with a plasmid encoding GFP-BtpB. Sixteen hours after transfection, cells were left untreated (A-D), or treated (E, F) with 1 μg/ml nocodazole for 30 min, fixed and stained with mouse anti β-tubulin antibody, followed by detection with anti-mouse Texas Red. (A). Confocal images of BtpB and the microtubule network. From left to right, merged stack images of 8 Z-slices of overlay, and individual GFP-BtpB (green) and tubulin (red) images are shown. Scale bar 10 μm. (B). Images, from left to right, show the individual Z-slices (0,3 μm depth) from the cell presented in A. The arrow head in panel 4 indicates GFP-BtpB accumulation in the nucleus. Boxed areas in panels 4 and 6 are shown enlarged in C and D. (C) Individual image (red filter) showing microtubule network at the MTOC (the lines indicate the area of GFP-BtpB colocalisation, as shown in the overlay image below). (D) Partial association of BtpB punctae and tubulin indicated with arrows. Enlargement (10x). (E) and (F) Confocal slices of HeLa cells after nocodazole treatment (+NC). Arrows indicate individual cells showing complete protection of nocodazole-induced microtubule depolymerization in transfected cells. Boxed areas are shown enlarged. Scale bar 10 μm. (E) Arrow head in enlarged image points at GFP-BtpB accumulation in the Midbody of the intercellular bridge.

Figure 5

WxxxE-dependent protection of microtubule from nocodazole-induced depolymerisation by BtpB. HeLa cells were transiently transfected with plasmids encoding GFP-BtpB (A-B), GFP-Btp W263S (C, D), or GFP-BtpB E267A (E, F). Sixteen hours after transfection, cells were left untreated (A, C, E), or treated (B, D, F) with 1 μg/ml nocodazole for 30 min, fixed and stained with mouse anti β-tubulin antibody, followed by detection with anti-mouse Texas Red. (A-F) Individual green and red fluorescence and overlay images of HeLa cells. Scale bar, 25 μm. Data are representative of 3 or more independent experiments.

The ability of BtpB to protect microtubules from degradation suggests that, like BtpA, BtpB might somehow associate with microtubules. Further inspection of confocal slices showed that cytoplasmic BtpB punctae showed partial colocalisation with β-tubulin (Figure 4B-D). In addition, our microscopic studies gave some further interesting observations. We often found GFP-BtpB foci at the microtubule-organizing centre (MTOC) (Figure 4C). Intriguingly, we observed that BtpB localised at a discrete ring structure in the intercellular bridge between dividing cells during late stages of cytokinesis and abscission, even in cells that had been treated with nocodazole (example shown in Figure 4E, Additional file 5: Figure S5B). Accumulated GFP-BtpB was still detected in post-mitotic midbodies (MB), associated with one of the two daughter cells after abscission, probably still connected through the thin stalk connected to the daughter cell [38].

Colocalisation studies with conjugated ubiquitin, using MAb FK2 that detects mono- and poly ubiquinated proteins, showed almost perfect colocalisation of GFP-BtpB punctae with conjugated ubiquitin, both in the cytoplasm and the nucleus. They also showed that the GFP-BtpB ring structure observed between dividing cells perfectly colocalised with FK2, demonstrating GFP-BtpB accumulates at the single, circular structure with densely ubiquitinated proteins that has been described to form in the midbody of the intercellular bridge [39] (Additional file 5: Figure S5A,B). Punctae with accumulated conjugated ubiquitin were also readily detectable in non-transfected cells (Additional file 5: Figure S5C), suggesting that in our cell transfection assays the local accumulation of conjugated ubiquitin is not dependent on BtpB overexpression. Together with the different observed subcellular localisation, these preliminary data suggest that BtpB is recruited to sites with high concentrations of ubiquitinated proteins, also during cytokinesis.

In line with our studies with BtpA, we further analysed the subcellular localisation of two GFP-BtpB WxxxE variants and their effect on the microtubule destabilising effects of nocodazole. Using site-directed mutagenesis, the substitutions W263S and E267A were introduced in the GFP-BtpB expression plasmid. Ectopic expression in HeLa cells often resulted in larger punctae than found for BtpB (Figure 5C, E). Treatment with nocodazole resulted in the formation of even larger GFP-BtpB aggregates than in non-treated cells, and these variant proteins were not able to stabilize microtubules (Figure 5D, F). These data show that also for BtpB the WxxxE motif is important for protection of microtubules.

Ectopic expression of BtpA induces formation of filopodia in a manner that is invariably dependent of the WxxxE motif

Despite low sequence conservation with proteins belonging to the family of bacterial WxxxE GEFs that modulate host actin dynamics, we were interested in a possible link of the Btp proteins with the actin network. Although we could not visually detect colocalisation with actin filaments in the cell for BtpA and BtpB, we detected actin rich cytoplasmic projections in HeLa cells expressing BtpA, but not BtpB, that we identified as filopodia (Figure 6). Distinctive filopodia that extend beyond the cell boundary were observed only in cells expressing GFP-BtpA, but not in non-transfected cells or the GFP control. We analysed the effect of ectopic expression of our panel of BtpA variants on the formation of filopodia. Interestingly, substitution of the conserved W and E residues, as well as G183, disrupted the ability of BtpA to induce filopodia; in contrast, the I226S variant was able to induce the formation of these actin filament bundles showing this residue is not critical for this (Table 1). These results clearly demonstrate that the conserved W213 and E217 residues are critical for the induction of filopodia in transfected HeLa cells by BtpA.
Figure 6

Ectopic expression of BtpA in HeLa cells induces filopodia. HeLa cells were transiently transfected with plasmids encoding GFP-BtpA. Sixteen hours after transfection the cells were fixed and actin was stained with Rhodamine phalloidin. Images were taken using confocal fluorescence microscopy. Large image on top, Z-Stack of 16 merged images slices (1 μm depth) of HeLa cells, showing actin distribution (red) and one cell expressing GFP-BtpA (green). The smaller images below are individual image slices. Scale bar, 25 μm. Data are representative of 3 or more independent experiments.


Intracellular bacterial pathogens employ secretion systems to introduce bacterial effectors directly into cells, where these proteins interfere with host cell biology and immune defences allowing the pathogen to survive and build an intracellular niche favourable to replication. Effectors from different pathogens have been shown to target many common cellular functions, including cytoskeleton dynamics, immune functions, GTPase signalling, host gene transcription, and ubiquitination. The stealth pathogen Brucella is famous for its silent entry into the host and avoidance of phagolysosomal degradation, and the translocated proteins BtpA and BtpB have been shown to contribute to this strategy by targeting the host's TLR-dependent arm of the innate immune defence [40]. Although studies are hampered by the lack of an attenuated virulence phenotype in cell culture systems (reviewed in [9]), recently Salcedo et al., using wild type mice, suggested that BtpA and BtpB contribute to virulence and control of local inflammatory responses [17].

The molecular mechanisms by which BtpA interferes with TLR4 and TLR2 signalling pathways remain controversial, due to the inconsistency between reports describing interaction with the adaptor proteins MyD88 and/or TIRAP/MAL [19],[24],[26],[27],[41]. Recent structural studies are now complementing biochemical, in vitro and overexpression studies, and the picture starts to emerge that BtpA may inhibit downstream MyD88-dependent signalling by competing with TIRAP in binding to the TLR4 receptor protein [25],[28],[29]. This process has been suggested to take place at the plasma membrane, possibly through a phosphoinositide interaction module with which BtpA inserts itself in the membrane [23]-[25]. However, the situation seems more complex, as BtpA has also been shown to be involved in microtubule dynamics and, very recently, in the induction of the unfolded protein response [30],[42].

Our data corroborated previous reports showing that BtpA interacts with microtubules in vitro[30], and that ectopically expressed BtpA formed a filamentous network in HeLa cells that partially colocalised with microtubules [24]. We found that this association was essential to block drug-induced depolymerisation of microtubules.

The second Brucella TIR protein, BtpB, has only recently been demonstrated to play a role in interference with TLR signalling [17], and the molecular mechanism of interference is as yet unknown. We were interested to find out whether BtpB is able to associate with the microtubule network. Here, we provide evidence that ectopically expressed BtpB equally protects microtubules from nocodazole-induced degradation in a WxxxE dependent manner. This result places BtpB at the interface of the microtubule network and TLR signalling, similar to BtpA. We observed partial colocalisation of visible BtpB punctae with β-tubulin in confocal slices, and the presence of BtpB punctae was correlated with better protection against microtubule depolymerisation. Our results further showed that BtpB colocalises with sites of accumulated ubiquitinated proteins, which were equally observed in non-transfected cells, not only in the cytoplasm but also in the nucleus and at a discrete region in the central spindle region between dividing cells, to which cytokinetic proteins are recruited to promote cell division. The central spindle is a bundle with interdigitated antiparallel microtubules between separating chromosomes. The FK2-positive Midbody ring has been shown to be a dynamic site of ubiquitination during the important later stages of cell division and abscission, when the cells finally detach [39]. More experiments are needed to determine if it is an association with microtubules or the UPS that causes the accumulation of ectopically expressed GFP-BtpB at the Midbody ring during cell division. Although colocalisation of BtpB punctae with conjugated ubiquitin raises the question as to whether BtpB itself could be sequestered by one of the cellular host mechanisms that deals with misfolded proteins [43]-[45], our preliminary observations provide an indication for a functional link of BtpB, microtubules and the Ubiquitin Proteasome system (UPS). Many viral and bacterial proteins have been shown to interfere with host ubiquitination processes [46],[47], and further experiments should provide more information whether BtpB could for instance enhance poly ubiquitination of TIR proteins, similar as shown for BtpA which targets the TIR adaptor TIRAP for degradation by polyubiquination [27].

Modulation of the host cytoskeleton by bacterial virulence factors is a common microbial strategy used by many pathogens at different stages of the infection process (reviewed in [48]. The actin network is often modulated by bacterial proteins that target the host small GTPases that are the essential signalling intermediates in actin dynamics [49]. During our studies we found that, besides colocalising with microtubules, ectopically expressed BtpA, but not BtpB, also induced actin rich filopodial protrusions in HeLa cells, a mainly Cdc42-dependent process. A WxxxE motif, that we identified in BtpA and BtpB led us to hypothesise that BtpA may induce GTPase activation in a similar manner as proteins belonging to the family of WxxxE/SopE T3SS effectors, most of which have been demonstrated to be Rho-GEFs. Ectopic expression of these WxxxE effectors has been shown to result in WxxxE-dependent formation of filopodia, stress fibers or lamellipodia, phenotypes that are typically associated with selective activation of the Rho GTPases Cdc42, RhoA and Rac1, respectively [34],[50]. Our expression studies in HeLa cells revealed that conservation of the W and E residues was crucial for the ability of BtpA to induce actin rearrangements, similar to the WxxxE GEF family effectors [32],[51],[52]. Although BtpA did not show sequence conservation with the different WxxxE GEF family proteins, the induction of filopodia in a WxxxE-dependent manner raised the question of whether BtpA could also function as a Cdc42 GEF, similar to the EPEC Map protein, that induces filopodia around the infecting bacterium [34],[50]. Despite many attempts, including direct RhoGEF exchange assays, we have, however, been unable to unambiguously show activation of Cdc42 by BtpA (not shown). To our knowledge, formation of functional filopodia has never been reported during Brucella infection; however, the ectopic induction of filopodia could be a consequence of activation of GTPases other than Cdc42, and play a localised intracellular role during Brucella infection. How ectopically expressed BtpA is able to induce these specific ectopically induced actin protrusions remains a subject for future studies.

We further analysed a role for the WxxxE motif in microtubule dynamics. Our mutagenesis studies revealed that the motif was not only required for induction of filopodia, but also for interaction with microtubules. Changes of both the Trp and the Glu residue affected BtpA localisation. As expected, proper subcellular localisation in tubular structures (albeit with different efficiencies for the individual variants) was required for microtubule protection for all analysed variants (Table 1). Changes to the Trp residue only affected the subcellular localisation efficiency but did not alter the ability of BtpA to protect microtubules once at the proper localization (W213F). Interestingly, however, negative charge at the Glu position seemed criticial for protection (the E217A variant was localised in tubules in about 53% of the transfected cells, yet could not protect microtubules). In addition, the motif was also important for the ability of BtpB to protect microtubules from degradation. Thus the WxxxE motif is important for microtubule protection by both BtpA and BtpB with, and negative charge in the WxxxE pocket may be crucial for this.

In the family of WxxxE GEFs, the conserved WxxxE motif has been shown to position a catalytic loop, that is essential for interaction with, and selective activation of specific Rho GTPase isoforms, exemplified by the interaction between Map and the β2-3 interswitch region of Cdc42 [31],[34]. Our recent resolution of the crystal structure of the BtpA TIR domain [28] shows that the WxxxE motif, located just adjacent of the αC helix in TIR box 2, positions the BB loop through interaction with a D residue (Figure 2B). Our mutagenesis results indicate that, although the motif is important for both colocalisation of BtpA with microtubules as well as its ability to protect microtubules from drug-induced degradation, minor differences in hydrophobic interaction in the WxxxE pocket between the different variants, may result in differences in positioning of the BB loop with either flexible (E217A) or stable conformations (E217D). This again may result in the observed differences in efficiency of colocalisation. Interestingly, this conformation positions the G183 residue that has been shown to be critical for interaction of BtpA with microtubules ([30] and this study), and shows that the WxxxE motif is an important structural motif in the interaction of BtpA with the microtubule network.

Extensive phylogenetic analysis identified 1688 TIR containing proteins, including 483 from both pathogenic and non-pathogenic bacteria [35]. We found that a WxxxE motif is present in a highly conserved region of almost all bacterial TIR proteins including the well-studied TcpC, PdTLP, SaTLP and TlpA [53], but also in eukaryotic TLR proteins TLR1, 2, 4, 6, and 10 and TIR adaptor protein SARM. Whereas positioning of a catalytic loop involved in interaction with GTPases has been described for members of the family of WxxxE GEFs, in bacterial TIR proteins the WxxxE motif may be involved in positioning residues important for association with microtubules, as shown for BtpA, or in positioning different loop structures.

Summarizing, our functional and structural studies show that the Brucella Btp proteins have a structural WxxxE motif important for their function. For several reasons, including little overall sequence conservation of BtpA and BtpB with the WxxxE/SopE family GEFs, the fact that BtpB does not induce any detectable actin rearrangements, and the conservation of the WxxxE motif in a large family of both pro- and eukaryotic TIR proteins, BtpA and BtpB are likely not part of the WxxxE family of GEFs. Recently, the Bartonella type IV secretion effector BepF, which has been shown to be involved in activation of Rac1 and Cdc42 in a WxxxE-dependent manner, has been suggested also likely not to represents a WxxxE/GEF family member [54]. This raises the question of whether there is an evolutionary advantage of the WxxxE motif as a strong structural determinant which may position important functional domains or catalytic sites. Further studies, however, are needed to define a possible role for the motif in other TIR domain containing proteins before conclusions can be drawn about the existence of other WxxxE families. Based on the WxxxE-dependent ability of ectopically expressed BtpA to induce filopodia, we propose that BtpA may help gain more insight into the frequently described cross talk between TLR and GTPase signalling networks [55],[56].

The precise role of BtpA and BtpB during Brucella infection remains unknown. Both proteins interfere with TLR signalling and somehow associate with microtubules, but they seem to be independently acquired functions. We believe that the GIs carrying btpA and btpB were acquired when the `classical' Brucella separated from the older species (B. inopinata, Australian rodent strains) and played a role in the development of this bacterium's `stealth' approach. The distribution of the GI carrying btpA suggests that it was lost through independent excision events several times in the evolution of the genus (Additional file 1: Figure S1). Whereas BtpB is present in all sequenced classical Brucella species, BtpA is absent in for instance B. suis. Interestingly, in all B. melitensis the tryptophan of the WxxxE motif has been changed into arginine. It remains to be analysed whether this rendered the protein non-functional, or whether it acquired other functions.

Interestingly, in dendritic cells, intracellular TLR2 and TLR4 have been shown to associate with microtubules and the Golgi, and this interaction was essential for IL-12 production in response to the intracellular pathogen Neisseria meningitides[57]. This situation seems reminiscent of the interaction of BtpA with TLR4 [25] and microtubules. We hypothesize that an intracellular TLR4 signalling complex is formed in endosomes that requires the microtubule network, and that BtpA interferes with locally induced signalling. Our findings that BtpB has a similar WxxxE-dependent microtubule protective role, but does not result in the induction of filopodia after ectopic expression, further suggests these two Brucella virulence proteins may play partially overlapping, yet different roles in virulence.

Materials and methods

Bacterial strains

For cloning Escherichia coli DH5α was cultured at 37°C in Luria-Bertani broth (LB) (Invitrogen, Merck). Kanamycin (25 μg/ml) or chloramphenicol (30 μg/ml) were added to the media when appropriate.

Plasmids and site-directed mutagenesis

A 828 bp version of the btpA gene was cloned from B. melitensis 16M genomic DNA (BMEI1674, Genbank accession NP_540591 is the shorter annotated version) using PCR (primers Bgl II L1674-F 5'-GAAGATCT TATGAGTTCGTACTCTTCTAATATTG-3', and Pst IL1674-R 5'-AACTGCAG TCAGATAAGGGAATGCAGTTC-3') and cloned in frame with the GFP coding sequence in eukaryotic expression plasmid pEGFP (Clontech) using standard protocols, resulting in plasmid pIN271.

A 978 version of the btpB gene was cloned from B. suis genomic DNA (BR0735, Genbank accession number AAN29664 is the shorter annotated version) using PCR (primers Bgl II 735-F 5'-GAAGATCT TATGACATCTAGTCGCGACACG-3', and Pst I 735-R 5'-AACTGCAG CTAGGTGATGAGGGCGACG-3') and cloned in frame with the GFP coding sequence in pEGFP resulting in plasmid pIN292. We amplified a longer version of btpB, which was recently also shown to complement a B. abortus btpB mutant in the control of NF-κB translocation into the nucleus [17].

Site directed mutagenesis of the WxxxE motif was done using the QuickChange Site-Directed Mutagenesis kit (Stratagene) following manufacturer's instructions, using pIN271 as a template with the following mutagenic primers for btpA (changed codons for Trp (TGG) and Glu (GAA) are italicised): W213A (5'-TTTAGCAAGCAAGCG CCCGCAAGAGAATTAG-3'), W213S (5'-TTTAGCAAGCAATCG CCCGCAAGAGAATTAG-3'), W213F (5'-TTTAGCAAGCAATTC CCCGCAAGAGAATTAG-3'), E217A (5'-CAATGGCCCGCAAGAGCA TTAGATGGACTGAC-3'), E217D (5'- CAATGGCCCGCAAGAGAT TTAGATGGACTGAC-3'), I226S (5'- CTGACGGCAATGGAAAGT GGCGGACAGACGC-3'), G183A (5'- CATATACGTTGAAGGTCGCT GACAGCCTTCGGCG-3'), and btpB (pIN292 as a template): W263S (5'- CTATCAGCGAAAAGACTCG TGCGGCGTCG-3') and E267A (5'- CTGGTGCGGCGTCGCG TTCCGCGCGATTCG-3'). Constructs were verified by DNA sequencing (Eurofins MWG operon, Germany). Table 2 summarizes the plasmids used in this study.
Table 2

Strains and plasmids used in this study

Strain or plasmid

Relevant characteristics


E. coli DH5α

DH5α F − 80lacZΔM15 Δ(lacZYA-argF)U169 endA1 recA1 hsdR17 (rK − mK+) supE44 thi-1ΔgyrA96 relA1



plasmid containing an enhanced GFP expression unit under control of the CMV promoter, Kmr



pEGFP derived plasmid containing GFP-btpA expression unit, Kmr

This Study


pIN271-derivative carrying btpA W213A

This Study


pIN271-derivative carrying btpA W213S

This Study


pIN271-derivative carrying btpA W213F

This Study


pIN271-derivative carrying btpA E217A

This Study


pIN271-derivative carrying btpA E217D

This Study


pIN271-derivative carrying btpA I262S

This Study


pIN271-derivative carrying btpA G183A

This Study


pIN271-derivative carrying btpB

This Study


pIN271-derivative carrying btpB W263S

This Study


pIN271-derivative carrying btpB E267A

This Study

Cell culture, transfection, immunocytochemistry, and fluorescence microscopy

HeLa cells were grown in RPMI 1640 (Gibco) supplemented with heat-inactivated 10% fetal bovine serum (FBS, Lonza, Switzerland). Transfections were performed using Lipofectamine 2000 (Invitrogen). For immuno fluorescence studies, cells were seeded on coverslips (BD Bioscience) and cultured overnight in 12-well dishes. Cells were transfected and, after 16–20 hours, treated with nocodazole (Sigma M1404) at a concentration of 1 μg/ml for 30 min if desired. Cells were fixed with 4% PFA, and processed for immunocytochemistry. Monoclonal mouse anti-β-tubulin (Sigma Aldrich, T4026), mouse anti-FK2 (Enzo Life science, BML-PW8810), Texas Red anti-mouse (Vector Laboratories, TI-2000), Rhodamin phalloidin (Invitrogen R415), Rabbit anti-BtpA (a gift from Marty Roop, East Carolina University, Greenville), FITC anti-rabbit (Vector Laboratories, FI-2000) were used for immune labelling. Immuno fluorescence microscopy was performed using a LEICA DM/IRB microscope using filter sets L5 (band pass (BP) 480/40; Beam splitter (BS) 505; emission BP527/30) and N2.1 (515–560; BS 580; emission long pass (LP) 590), respectively. For imaging we used a Coolsnap fx (Roper Scientifique) and MetaVue software, and images were further processed using Adobe Photoshop. Confocal analysis was performed at the RIO imaging platform in Montpellier, with a Biorad MRC1024 confocal microscope.

Bio informatic analysis

Brucella genomes were obtained and compared on the PATRIC website [33]. Sequence alignments were performed using T-Coffee analysis, and further analysed using Jalview. Structural figures were generated with Pymol (

Additional files



Guanidine exchange factors




Microtubule-organizing centre




Toll/Interleukin-1 receptor


Toll like receptor


Type IV secretion system


Type III secretion system


Ubiquitin Proteasome system



The authors thank Marty Roop for BtpA antibodies, and Philippe Fort and Géraldine Pawlak for helpful discussions. We thank Montpellier RIO imaging for confocal microscopy. U1047 received funding from INSERM, Université Montpellier 1, the Region Languedoc-Roussillon, the Agence Nationale de Recherche (ANR-MIME; T4SS, ANR-MIE; BruCell). Work in the LT group was funded by the ATIP-Avenir program from the CNRS and Ligue Contre le Cancer.

Authors’ Affiliations

INSERM U1047, Université Montpellier 1, UFR Médecine
UMR 5086, BMSSI, CNRS- Université Lyon 1, Institut de Biologie et Chimie des Protéines
Current address: Faculty of Engineering, Department of Food Engineering, Ege University


  1. O’Callaghan D, Whatmore AM: Brucella genomics as we enter the multi-genome era. Brief Funct Genomics. 2011, 10: 334-341. 10.1093/bfgp/elr026.PubMedView ArticleGoogle Scholar
  2. Martirosyan A, Moreno E, Gorvel J-P: An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev. 2011, 240: 211-234. 10.1111/j.1600-065X.2010.00982.x.PubMedView ArticleGoogle Scholar
  3. Cardoso PG, Macedo GC, Azevedo V, Oliveira SC: Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb Cell Fact. 2006, 5: 13-10.1186/1475-2859-5-13.PubMedPubMed CentralView ArticleGoogle Scholar
  4. Celli J: Surviving inside a macrophage: the many ways of Brucella. Res Microbiol. 2006, 157: 93-98. 10.1016/j.resmic.2005.10.002.PubMedView ArticleGoogle Scholar
  5. De Jong MF, Rolán HG, Tsolis RM: Innate immune encounters of the (Type) 4th kind: Brucella. Cell Microbiol. 2010, 12: 1195-1202. 10.1111/j.1462-5822.2010.01498.x.PubMedView ArticleGoogle Scholar
  6. Seleem MN, Boyle SM, Sriranganathan N: Brucella: a pathogen without classic virulence genes. Vet Microbiol. 2008, 129: 1-14. 10.1016/j.vetmic.2007.11.023.PubMedView ArticleGoogle Scholar
  7. Llosa M, Roy C, Dehio C: Bacterial type IV secretion systems in human disease. Mol Microbiol. 2009, 73: 141-151. 10.1111/j.1365-2958.2009.06751.x.PubMedPubMed CentralView ArticleGoogle Scholar
  8. Bhatty M, Laverde Gomez JA, Christie PJ: The expanding bacterial type IV secretion lexicon. Res Microbiol. 2013, 164: 620-639. 10.1016/j.resmic.2013.03.012.PubMedView ArticleGoogle Scholar
  9. Von Bargen K, Gorvel J-P, Salcedo SP: Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev. 2012, 36: 533-562. 10.1111/j.1574-6976.2012.00334.x.PubMedView ArticleGoogle Scholar
  10. O’ Callaghan D, Cazevieille C, Allardet-Servent A, Boschiroli ML, Bourg G, Foulongne V, Frutos P, Kulakov Y, Ramuz M: A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol Microbiol. 1999, 33: 1210-1220. 10.1046/j.1365-2958.1999.01569.x.View ArticleGoogle Scholar
  11. Starr T, Ng TW, Wehrly TD, Knodler LA, Celli J: Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment. Traffic. 2008, 9: 678-694. 10.1111/j.1600-0854.2008.00718.x.PubMedView ArticleGoogle Scholar
  12. Lavigne J-P, Patey G, Sangari FJ, Bourg G, Ramuz M, O’Callaghan D, Michaux-Charachon S: Identification of a New Virulence Factor, BvfA, in Brucella suis. Infect Immun. 2005, 73: 5524-5529. 10.1128/IAI.73.9.5524-5529.2005.PubMedPubMed CentralView ArticleGoogle Scholar
  13. De Jong MF, Sun Y-H, den Hartigh AB, van Dijl JM, Tsolis RM: Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol Microbiol. 2008, 70: 1378-1396. 10.1111/j.1365-2958.2008.06487.x.PubMedPubMed CentralView ArticleGoogle Scholar
  14. De Barsy M, Jamet A, Filopon D, Nicolas C, Laloux G, Rual J-F, Muller A, Twizere J-C, Nkengfac B, Vandenhaute J, Hill DE, Salcedo SP, Gorvel J-P, Letesson J-J, De Bolle X: Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2. Cell Microbiol. 2011, 13: 1044-1058. 10.1111/j.1462-5822.2011.01601.x.PubMedView ArticleGoogle Scholar
  15. Marchesini MI, Herrmann CK, Salcedo SP, Gorvel J-P, Comerci DJ: In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system. Cell Microbiol. 2011, 13: 1261-1274. 10.1111/j.1462-5822.2011.01618.x.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Myeni S, Child R, Ng TW, Kupko JJ, Wehrly TD, Porcella SF, Knodler LA, Celli J: Brucella Modulates Secretory Trafficking via Multiple Type IV Secretion Effector Proteins. PLoS Pathog. 2013, 9: e1003556-10.1371/journal.ppat.1003556.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Salcedo SP, Marchesini MI, Degos C, Terwagne M, Von Bargen K, Lepidi H, Herrmann CK, Santos Lacerda TL, Imbert PRC, Pierre P, Alexopoulou L, Letesson JJ, Comerci DJ, Gorvel JP: BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Front Cell Infect Microbiol. 2013, 3: 28-10.3389/fcimb.2013.00028.PubMedPubMed CentralGoogle Scholar
  18. Newman RM, Salunkhe P, Godzik A, Reed JC: Identification and Characterization of a Novel Bacterial Virulence Factor That Shares Homology with Mammalian Toll/Interleukin-1 Receptor Family Proteins. Infect Immun. 2006, 74: 594-601. 10.1128/IAI.74.1.594-601.2006.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T: Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med. 2008, 14: 399-406. 10.1038/nm1734.PubMedView ArticleGoogle Scholar
  20. Kawai T, Akira S: Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity. 2011, 34: 637-650. 10.1016/j.immuni.2011.05.006.PubMedView ArticleGoogle Scholar
  21. Rana RR, Zhang M, Spear AM, Atkins HS, Byrne B: Bacterial TIR-containing proteins and host innate immune system evasion. Med Microbiol Immunol. 2013, 202: 1-10. 10.1007/s00430-012-0253-2.PubMedView ArticleGoogle Scholar
  22. Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, Balor S, Muller A, Lapaque N, Demaria O, Alexopoulou L, Comerci DJ, Ugalde RA, Pierre P, Gorvel J-P: Brucella Control of Dendritic Cell Maturation Is Dependent on the TIR-Containing Protein Btp1. PLoS Pathog. 2008, 4: e21-10.1371/journal.ppat.0040021.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Radhakrishnan GK, Splitter GA: Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis. Biochem Biophys Res Commun. 2010, 397: 59-63. 10.1016/j.bbrc.2010.05.056.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Radhakrishnan GK, Yu Q, Harms JS, Splitter GA: Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP. J Biol Chem. 2009, 284: 9892-9898. 10.1074/jbc.M805458200.PubMedPubMed CentralView ArticleGoogle Scholar
  25. Alaidarous M, Ve T, Casey LW, Valkov E, Ericsson DJ, Ullah MO, Schembri MA, Mansell A, Sweet MJ, Kobe B: Mechanism of bacterial interference with TLR4 signaling by Brucella TIR-domain-containing protein TcpB. J Biol Chem. 2013, 289: 654-668. 10.1074/jbc.M113.523274.PubMedPubMed CentralView ArticleGoogle Scholar
  26. Chaudhary A, Ganguly K, Cabantous S, Waldo GS, Micheva-Viteva SN, Nag K, Hlavacek WS, Tung C-S: The Brucella TIR-like protein TcpB interacts with the death domain of MyD88. Biochem Biophys Res Commun. 2012, 417: 299-304. 10.1016/j.bbrc.2011.11.104.PubMedPubMed CentralView ArticleGoogle Scholar
  27. Sengupta D, Koblansky A, Gaines J, Brown T, West AP, Zhang D, Nishikawa T, Park S-G, Roop RM, Ghosh S: Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J Immunol. 2010, 184: 956-964. 10.4049/jimmunol.0902008.PubMedPubMed CentralView ArticleGoogle Scholar
  28. Kaplan-Türköz B, Koelblen T, Felix C, Candusso M-P, O’Callaghan D, Vergunst AC, Terradot L: Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpB. FEBS Lett. 2013, 587: 3412-3416. 10.1016/j.febslet.2013.09.007.PubMedView ArticleGoogle Scholar
  29. Snyder GA, Deredge D, Waldhuber A, Fresquez T, Wilkins DZ, Smith PT, Duerr S, Cirl C, Jiang J, Jennings W, Luchetti T, Snyder N, Sundberg EJ, Wintrode P, Miethke T, Xiao TS: Crystal structures of the TIR domains from the Brucella protein TcpB and host adapter TIRAP reveal mechanisms of molecular mimicry. J Biol Chem. 2014, 289: 669-679. 10.1074/jbc.M113.523407.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Radhakrishnan GK, Harms JS, Splitter GA: Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis. Biochem J. 2011, 439: 79-83. 10.1042/BJ20110577.PubMedPubMed CentralView ArticleGoogle Scholar
  31. Orchard RC, Alto NM: Mimicking GEFs: A Common Theme For Bacterial Pathogens. Cell Microbiol. 2012, 14: 10-18. 10.1111/j.1462-5822.2011.01703.x.PubMedPubMed CentralView ArticleGoogle Scholar
  32. Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, McMahon SA, Ghosh P, Hughes TR, Boone C, Dixon JE: Identification of a bacterial type III effector family with G protein mimicry functions. Cell. 2006, 124: 133-145. 10.1016/j.cell.2005.10.031.PubMedView ArticleGoogle Scholar
  33. Wattam AR, Abraham D, Dalay O, Disz TL, Driscoll T, Gabbard JL, Gillespie JJ, Gough R, Hix D, Kenyon R, Machi D, Mao C, Nordberg EK, Olson R, Overbeek R, Pusch GD, Shukla M, Schulman J, Stevens RL, Sullivan DE, Vonstein V, Warren A, Will R, Wilson MJC, Yoo HS, Zhang C, Zhang Y, Sobral BW: PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res. 2014, 42: D581-D591. 10.1093/nar/gkt1099.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, Chai J, Alto NM: Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol. 2009, 16: 853-860. 10.1038/nsmb.1647.PubMedView ArticleGoogle Scholar
  35. Zhang Q, Zmasek CM, Cai X, Godzik A: TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog. Dev Comp Immunol. 2011, 35: 461-468. 10.1016/j.dci.2010.11.013.PubMedPubMed CentralView ArticleGoogle Scholar
  36. Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG: The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006, 7: 1074-1081. 10.1038/ni1382.PubMedView ArticleGoogle Scholar
  37. Bulgin R, Raymond B, Garnett JA, Frankel G, Crepin VF, Berger CN, Arbeloa A: Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect Immun. 2010, 78: 1417-1425. 10.1128/IAI.01250-09.PubMedPubMed CentralView ArticleGoogle Scholar
  38. Chen C-T, Ettinger AW, Huttner WB, Doxsey SJ: Resurrecting remnants: the lives of post-mitotic midbodies. Trends Cell Biol. 2013, 23: 118-128. 10.1016/j.tcb.2012.10.012.PubMedPubMed CentralView ArticleGoogle Scholar
  39. Mukai A, Mizuno E, Kobayashi K, Matsumoto M, Nakayama KI, Kitamura N, Komada M: Dynamic regulation of ubiquitylation and deubiquitylation at the central spindle during cytokinesis. J Cell Sci. 2008, 121: 1325-1333. 10.1242/jcs.027417.PubMedView ArticleGoogle Scholar
  40. Ben Tekaya H, Gorvel JP, Dehio C: Bartonella and Brucella--weapons and strategies for stealth attack. Cold Spring Harb Perspect Med. 2013, 3. doi:10.1101/cshperspect.a010231Google Scholar
  41. Fekonja O, Benčina M, Jerala R: Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling. J Biol Chem. 2012, 287: 30993-31002. 10.1074/jbc.M112.376186.PubMedPubMed CentralView ArticleGoogle Scholar
  42. Smith JA, Khan M, Magnani DD, Harms JS, Durward M, Radhakrishnan GK, Liu Y-P, Splitter GA: Brucella Induces an Unfolded Protein Response via TcpB That Supports Intracellular Replication in Macrophages. PLoS Pathog. 2013, 9: e1003785-10.1371/journal.ppat.1003785.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Hanson PI, Cashikar A: Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012, 28: 337-362. 10.1146/annurev-cellbio-092910-154152.PubMedView ArticleGoogle Scholar
  44. Lafarga M, Berciano MT, Pena E, Mayo I, Castan G, Bohmann J, Pedro Rodrigues D, Paulo J, Tavanez J, Carmo Fonseca M: Clastosome: A Subtype of Nuclear Body Enriched in 19S and 20S Proteasomes, Ubiquitin, and Protein Substrates of Proteasome. Mol Biol Cell. 2002, 13: 2771-2782. 10.1091/mbc.E02-03-0122.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Kopito RR: Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 68: 524-530. 10.1016/S0962-8924(00)01852-3.View ArticleGoogle Scholar
  46. Angot A, Vergunst A, Genin S, Peeters N: Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog. 2007, 3: e3-10.1371/journal.ppat.0030003.PubMedPubMed CentralView ArticleGoogle Scholar
  47. Ashida H, Kim M, Sasakawa C: Exploitation of the host ubiquitin system by human bacterial pathogens. Nat Rev Microbiol. 2014, 12: 399-413. 10.1038/nrmicro3259.PubMedView ArticleGoogle Scholar
  48. Radhakrishnan GK, Spliiter GA: Modulation of host microtubule dynamics by pathogenic bacteria. Biomol Concepts. 2012, 3: 571-580. 10.1515/bmc-2012-0030.PubMedPubMed CentralView ArticleGoogle Scholar
  49. Aktories K: Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol. 2011, 9: 487-498. 10.1038/nrmicro2592.PubMedView ArticleGoogle Scholar
  50. Kenny B, Ellis S, Leard AD, Warawa J, Mellor H, Jepson MA: Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol. 2002, 44: 1095-1107. 10.1046/j.1365-2958.2002.02952.x.PubMedView ArticleGoogle Scholar
  51. Arbeloa A, Bulgin RR, MacKenzie G, Shaw RK, Pallen MJ, Crepin VF, Berger CN, Frankel G: Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell Microbiol. 2008, 10: 1429-1441. 10.1111/j.1462-5822.2008.01136.x.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Berger CN, Crepin VF, Jepson MA, Arbeloa A, Frankel G: The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell Microbiol. 2009, 11: 309-322. 10.1111/j.1462-5822.2008.01254.x.PubMedPubMed CentralView ArticleGoogle Scholar
  53. Cirl C, Miethke T: Microbial Toll/interleukin 1 receptor proteins: a new class of virulence factors. Int J Med Microbiol. 2010, 300: 396-401. 10.1016/j.ijmm.2010.04.001.PubMedView ArticleGoogle Scholar
  54. Truttmann MC, Guye P, Dehio C: BID-F1 and BID-F2 Domains of Bartonella henselae Effector Protein BepF Trigger Together with BepC the Formation of Invasome Structures. PLoS ONE. 2011, 6: e25106-10.1371/journal.pone.0025106.PubMedPubMed CentralView ArticleGoogle Scholar
  55. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG: Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol. 2000, 1: 533-540. 10.1038/82797.PubMedView ArticleGoogle Scholar
  56. Van Acker T, Eyckerman S, Vande Walle L, Gerlo S, Goethals M, Lamkanfi M, Bovijn C, Tavernier J, Peelman F: The Small GTPase Arf6 Is Essential for the Tram/Trif Pathway in TLR4 Signaling. J Biol Chem. 2014, 289: 1364-1376. 10.1074/jbc.M113.499194.PubMedPubMed CentralView ArticleGoogle Scholar
  57. Uronen-Hansson H, Allen J, Osman M, Squires G, Klein N, Callard RE: Toll-like receptor 2 ( TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface : integrity of microtubules is required for interleukin-12 production in resp. Immunology. 2004, 111: 173-178. 10.1111/j.0019-2805.2003.01803.x.PubMedPubMed CentralView ArticleGoogle Scholar


© Felix et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.